🇺🇸

US SEC Filing Intelligence

· daily

Defense Manufacturing Contracts — June 25, 2026

The single contract in this period, a $538.5M NASA cost-plus incentive fee award to Lockheed Martin for the Low Boom Flight Demonstrator (LBFD), represents a pure civilian R&D program with no direct defense linkage. While the contract signals Lockheed Martin's competitive strength in advanced aircraft manufacturing and provides steady, low-risk cash flow (73% already outlaid), its single-customer, research-focused nature limits revenue visibility and scalability. The highest-conviction signal is neutral-to-bullish given the full-and-open competition win and cost-plus pricing, but the key risk is program termination or budget reallocation post-2026. Investors should watch for milestone achievements and potential contract extensions as catalysts.

1 total filings
· daily

VA Healthcare & Services Contracts — June 25, 2026

This digest covers a single, large civilian contract from the Department of Veterans Affairs (VA) totaling $67.4 million, with zero defense-related exposure. The dominant theme is VA IT infrastructure modernization, specifically through a Service Disabled Veteran Owned Small Business (SDVOSB) set-aside. The highest-conviction signal is neutral: the award to V3GATE, LLC signals strong SDVOSB positioning in VA procurement, but the contract is in its earliest execution stage with only $5,772 outlaid, creating execution risk under a firm-fixed-price structure. Key watch items include revenue recognition pace over the next six months and the likelihood of option exercise, which could expand the total potential value to $263.1 million.

1 total filings
· daily

HHS & Healthcare Contracts Intelligence — June 25, 2026

This digest covers a single civilian contract from the Department of Health and Human Services (HHS), specifically the NIH National Cancer Institute (NCI), with a total obligation of $63.1 million awarded to Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings, Inc. The contract is a cost-plus-fixed-fee delivery order for R&D facility operations, reflecting a stable but low-margin revenue stream for Leidos. The neutral signal strength (5/10) and low materiality (4/10) indicate this award is not transformative for Leidos, given its one-year performance period and full competition. Key risks include the short duration and lack of option exercise, while the NIH's consistent cancer research funding provides a supportive backdrop for potential follow-on awards.

1 total filings
· daily

New Federal Contractors — June 25, 2026

This digest of 17 new federal contracts, totaling $1.63 billion, reveals a predominantly civilian-driven procurement landscape, with only 3 defense-related awards. The dominant theme is stable, recurring spending by civilian agencies (NASA, Department of State, GSA, VA, Interior, HHS, DOL, Commerce, EPA, DOE, DOT, Treasury) on IT services, logistics, and environmental remediation. The highest-conviction signal is a bullish $125.5M firm-fixed-price contract to Life Science Logistics LLC from GSA for refrigerated warehousing, indicating strong cash flow and potential for margin upside. A key risk is the high number of neutral signals (15 out of 17), reflecting the mature, cost-plus nature of many awards and the early-stage execution of several large contracts, which limits near-term upside surprise for investors.

17 total filings
· daily

Significant Contract Modifications ($10M+) — June 25, 2026

The 17 government contracts analyzed, totaling $1.63 billion in obligations, reveal a predominantly civilian-driven procurement landscape with only 3 defense-related awards. The dominant theme is sustained federal investment in IT services, health IT, and environmental remediation, with NASA's $538.5M Low Boom Flight Demonstrator contract to Lockheed Martin representing the highest-conviction signal due to its cost-plus structure and competitive win. However, the digest is characterized by neutral signals (15 of 17), reflecting mature, low-margin contracts with limited upside surprise. Key risks include concentration in civilian agencies (e.g., Department of the Interior, IRS) and execution risk on fixed-price contracts like Life Science Logistics' $125.5M warehousing deal. Investors should watch for option exercises on the $263.1M VA IT contract to V3GATE and follow-on awards for the Department of Labor's Job Corps program.

17 total filings
· daily

Contract Deobligations Alert — June 25, 2026

This digest of 17 government contracts, with a total obligation of $1.63 billion, reveals a predominantly civilian-driven procurement landscape, with only 3 of the contracts defense-related. NASA and Department of Health/Interior/Treasury agencies dominate the spending. The highest-conviction signal is Life Science Logistics's $125.5M firm-fixed-price award from GSA for pharmaceutical warehousing, which offers strong near-term cash flow ($103M already outlaid) and multi-year revenue visibility ($215.4M potential). A key risk is the heavy concentration of awards nearing completion or in early stages (e.g., V3GATE's VA contract has only $5,772 outlaid), which creates forward revenue uncertainty. The digest shows no clear bearish trend, but execution risk is elevated on several early-stage contracts.

17 total filings
· daily

Contract Option Exercises — June 25, 2026

This digest synthesizes 17 contract option exercises totaling $1.63 billion, dominated by civilian agency awards (14 of 17) with only 3 defense-related contracts. The largest single award is Lockheed Martin's $538.5M NASA Low Boom Flight Demonstrator contract, a neutral-to-bullish signal given its cost-plus structure and 73% completion rate. The highest-conviction bullish signals come from Life Science Logistics' $125.5M GSA refrigerated warehousing contract and ARBOR E & T LLC's $59.8M DOL Job Corps award, both offering predictable, multi-year revenue streams. Key risk: 15 of 17 contracts are rated neutral, reflecting limited transformative revenue visibility across the cohort, with several contracts nearing completion (e.g., ADAMS AND ASSOCIATES at 97% outlayed). Investors should watch for option exercises on the Life Science Logistics and ARBOR E & T contracts as near-term catalysts.

17 total filings
· daily

Federal IT & Cybersecurity Contracts — June 25, 2026

This digest of 6 federal IT and cybersecurity contracts, totaling $464.6 million in obligations, reveals a pronounced civilian agency focus, with only one contract (ManTech's $66.1M DOI award) indirectly supporting defense health IT. The Department of the Treasury (IRS) and Department of Veterans Affairs dominate, accounting for $166.8M combined, signaling sustained investment in legacy IT modernization and endpoint infrastructure. The highest-conviction signal is the V3GATE, LLC $67.4M VA award with a $263.1M ceiling, representing a multi-year growth opportunity for a small SDVOSB in a stable agency budget environment. However, the digest is uniformly neutral (0 bullish, 0 bearish), reflecting early-stage execution risk (V3GATE has only $5,772 outlaid) and fixed-price pricing risk across several contracts. Key watch items include option exercise announcements for V3GATE and LANCER's IRS VMware contract, which will determine revenue durability.

6 total filings
· daily

NASA & Space Contracts Intelligence — June 25, 2026

This digest covers a single $538.5M NASA contract awarded to Lockheed Martin for the Low Boom Flight Demonstrator (LBFD) supersonic research aircraft. The contract is entirely civilian (NASA), with no defense-related obligations, and represents a stable, cost-plus incentive fee arrangement that reduces Lockheed Martin's financial risk. The highest-conviction signal is neutral-to-bullish given the full-and-open competition win and strong execution progress (73% outlaid), but the research-focused nature limits revenue visibility. Key risk is the single-customer concentration and potential budget shifts for supersonic R&D beyond 2026.

1 total filings
· daily

All HHS Contracts — June 25, 2026

The single HHS contract analyzed for June 25, 2026, a $63.1M cost-plus-fixed-fee delivery order awarded to Leidos Biomedical Research Inc. by NIH/NCI for R&D facility operations, is purely civilian, defense-unrelated, and carries a neutral signal (strength 5/10). Revenue is steady but non-transformative for Leidos Holdings, representing approximately 0.1% of annual revenue, with low pricing risk but limited upside given the cost-plus structure and short one-year performance period. The highest-conviction signal is stability in NIH cancer research funding, though the absence of option exercise or follow-on awards introduces revenue discontinuity risk. Key watch item is re-competition timing at NIH NCI for similar GOCO facility operations contracts.

1 total filings
· daily

All DOE Contracts — June 25, 2026

This digest covers a single Department of Energy (DOE) contract worth $53.1 million, awarded to Central Plateau Cleanup Company, LLC (a subsidiary of Centra Technology Inc) for remediation services at the Hanford site. The contract is entirely civilian, with no defense-related exposure, and represents a low-risk, cost-plus-fixed-fee structure that limits profit volatility. The highest-conviction signal is neutral: the award provides stable, predictable revenue but is modest in scale and early-stage, with only $9.2 million outlayed to date. Key risks include execution pace uncertainty and the need to monitor definitization of the task order, as well as the contract's modest size relative to large-cap portfolios.

1 total filings
· daily

Mega Contracts Monitor ($100M+) — June 25, 2026

This digest covers $833.9M in contracts awarded between 2018 and 2021, with only one-third defense-related (NASA supersonic research) and the remainder civilian (State Department IT, GSA logistics). The highest-conviction signal is a bullish $125.5M firm-fixed-price award to Life Science Logistics LLC for refrigerated pharmaceutical warehousing, which already shows $103M in outlays and a potential $215.4M ceiling, indicating strong cash flow and execution momentum. A key risk is the $538.5M Lockheed Martin NASA contract, which is 73% complete and offers limited future revenue visibility beyond 2026. The dominant theme is civilian agency logistics and IT modernization, not defense spending, which may shift investor focus toward government services and cold-chain logistics providers.

3 total filings
· daily

High-Value Federal Grants ($5M+) — June 25, 2026

This digest synthesizes 17 high-value federal grants totaling $1.63 billion, with only 3 of 17 contracts defense-related, underscoring a civilian-agency-heavy procurement landscape. The dominant sector theme is IT services and health IT modernization, with notable awards to General Dynamics Information Technology ($61.7M) and ManTech ($66.1M) for civilian agency IT and health data systems. The highest-conviction signal is the Life Science Logistics LLC $125.5M firm-fixed-price contract for refrigerated warehousing and emergency response, which shows strong cash flow ($103M outlaid) and a potential $215.4M ceiling, indicating a durable, high-margin revenue stream. A key risk is the concentration of awards to small businesses and set-aside entities (e.g., TECHNIKO LLC, V3GATE, LLC), which may limit scalability for large-cap investors and introduce execution risk on fixed-price contracts.

17 total filings
· daily

DOE Energy Grants — June 25, 2026

This digest covers a single, civilian Department of Energy (DOE) contract worth $53.1 million awarded to Central Plateau Cleanup Company, LLC, a subsidiary of Centra Technology Inc, for remediation services at the Hanford site. The award is a cost-plus-fixed-fee task order, signaling low execution risk for the contractor but limited upside from cost efficiencies. With only $9.2 million outlayed to date, the contract is in early-stage execution, and the neutral signal strength (5/10) reflects stable, low-growth revenue from a legally mandated cleanup program. The key watch item is the definitization of the task order and future outlay pace, which will confirm funding stability and execution cadence. No defense-related contracts were recorded in this period, underscoring a purely civilian, environmental management theme.

1 total filings
· daily

General Federal Contracts — June 25, 2026

Across 17 contracts totaling $1.63B, the digest reveals a heavily civilian-skewed procurement landscape (14 of 17 contracts, 86% of obligation) dominated by IT services, environmental remediation, and vocational training — not defense. The highest-conviction signals are a $125.5M GSA cold chain logistics award to Life Science Logistics (bullish, predictable cash flow) and a $59.8M Department of Labor Job Corps contract to ARBOR E & T LLC (bullish, full-and-open win). The largest contract by value is Lockheed Martin’s $538.5M NASA supersonic research award, but its neutral signal reflects single-customer risk and mature execution (~73% outlayed). Key risks include contract cliff exposure at Riverside Technology ($57.9M, expiring Feb 2024) and the absence of large defense prime wins (only Lockheed Martin and Textron Aviation have defense-adjacent contracts). The highest materiality contract is Life Science Logistics’ GSA award, which already shows $103M outlayed against a $125.5M obligation, signaling strong near-term cash conversion. Investors should watch for option exercises on the $175M GDIT IHS EHR contract and the $263.1M V3GATE VA IT delivery order as bellwethers for civilian health IT spending momentum.

17 total filings
· daily

All NASA Contracts — June 25, 2026

Over a single day of NASA contracting activity (June 25, 2026), the agency obligated $646M across three awards, with zero defense-related content—a pure civilian R&D portfolio dominated by a single $538.5M Lockheed Martin cost-plus incentive fee contract for the Low Boom Flight Demonstrator (LBFD) supersonic research aircraft. The aggregate signal strength is a neutral 5.0/10, reflecting stable, low-risk cost-plus pricing but limited revenue visibility beyond 2026. The highest-conviction signal is Lockheed Martin's full-and-open competitive win, reinforcing its moat in advanced aircraft manufacturing, though the research-only nature caps production upside. Key risk: the LBFD contract is 73% complete with no follow-on production guarantee, creating a revenue cliff for Lockheed Martin post-2026 if NASA does not extend or modify the program.

3 total filings
· daily

S&P 500 Technology Sector SEC Filings — June 25, 2026

The four filings reveal a stark divergence within the S&P 500 Technology sector. Micron Technology's 10-Q showcases explosive growth, with revenue surging 346% YoY to $41.5B, driven by AI-related memory demand, resulting in a net income leap to $28.2B and EPS of $24.67. This signals a powerful cyclical upswing in semiconductors. In contrast, the three CrowdStrike filings paint a picture of sustained insider selling, with the CEO and Chief Accounting Officer collectively disposing of over $1.7M in stock via pre-arranged 10b5-1 plans. While these sales are planned, the consistent pattern of monetization by top executives at elevated stock prices (~$680) warrants attention, especially as the company has not filed a quarterly report in this batch to confirm operational momentum. The key portfolio-level theme is a 'barbell' effect: one company is in a high-growth, high-profit phase, while another shows insider profit-taking that may signal a peak in valuation sentiment. The most critical development is Micron's massive earnings beat, which reinforces the AI infrastructure buildout narrative, while CrowdStrike's insider activity introduces a note of caution for cybersecurity valuations.

4 high priority 4 total filings
· daily

Nasdaq 100 Stocks SEC Filings — June 25, 2026

The two filings from the NASDAQ-100 universe present a stark contrast. Micron Technology reported a phenomenal quarter, with revenue surging 346% YoY to $41.5B and net income skyrocketing to $28.2B, driven by explosive AI-related memory demand. This represents a massive inflection point for the semiconductor sector. In contrast, a director sale at Costco, while relatively small in value ($847K), signals potential insider caution at the retail giant's current elevated valuation. The overarching theme is the bifurcation between the AI-driven growth cycle in semiconductors and the mature, high-valuation environment in consumer staples. The lack of forward-looking guidance from Micron in this filing is a notable gap, but the operational momentum is undeniable.

2 high priority 2 total filings
· daily

US Activist Hedge Fund Institutional SEC 13D 13G — June 25, 2026

The 29 filings reveal a significant wave of post-bankruptcy ownership restructuring in the real estate sector, with Office Properties Income Trust emerging from Chapter 11 and attracting two major institutional blocks (Helix Partners at 25.3% and Redwood Capital at 19.7%), signaling a potential turnaround play. A clear pattern of rapid stake accumulation and subsequent divestment by Millennium Management in two quantum computing IPOs (Xanadu and Horizon Quantum) suggests a short-term arbitrage strategy rather than long-term conviction, raising caution flags for the sector. Insider selling is concentrated: BW Group reduced its Navigator Holdings stake by 11.6% over a month, while Mantle Ridge fully exited Dollar Tree after a multi-year activist campaign, distributing shares to limited partners. Conversely, insider buying is evident at American Shared Hospital Services, where the Executive Chairman increased his stake to 33% at $2.28/share, signaling deep value conviction. Passive institutional stakes (13G filings) continue to accumulate in small-cap biotech and tech, with Point72, EcoR1 Capital, and Glazer Capital all taking 5%+ positions, suggesting selective bottom-fishing. The most material event is the LakeShore Biopharma merger completion at $0.066/share, a near-total loss for prior equity holders. Overall, the digest points to a bifurcated market: distressed real estate and small-cap biotech attracting activist and institutional interest, while quantum computing and certain consumer names see rapid institutional exits.

13 high priority 16 medium 29 total filings
· daily

S&P 500 Financials Sector SEC Filings — June 25, 2026

The three financial sector filings for June 25, 2026, present a muted picture dominated by regulatory processes and administrative changes, with one notable insider selling event creating a bearish signal for Progressive. American Express disclosed its DFAST results, a routine regulatory milestone that offers no immediate market-moving information but maintains the company's compliance standing. JPMorgan Chase’s filing regarding a director or officer change is procedural and carries minimal materiality. However, the Progressive insider sale of $1.5 million by a director, combined with the absence of any positive operational catalysts across the filings, tilts the sector sentiment slightly negative, suggesting potential caution among specific leadership. The overall lack of new forward-looking guidance, earnings reports, or capital allocation announcements across these three companies highlights a quiet period for the financials sector, with no cross-cutting trends or broad-based themes emerging from this small sample.

2 high priority 1 medium 3 total filings